Skip to content
Recall Observatory FDA recall evidence

Drug product

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534

D-0617-2024

June 21, 2024

Class II

Product summary

Firm
Zydus Pharmaceuticals (USA) Inc
Event
Event 94850
Status
Terminated
Classification
Class II
Quantity
a) 13,128 bottles; b) 252 bottles
Official record key
drug-enforcement:D-0617-2024

Official wording

Reason: Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

Code information: Lot #: a) M213175, Exp. Date 09/2024; b) M213176, Exp. Date 09/2024

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification